Insider · CIK 0001410289
Mary T Szela
ceopresidentofficerdirector
Files at KURA (Kura Oncology, Inc.), ABSI (Absci Corp), TLSI (TriSalus Life Sciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | TLSI TriSalus Life Sciences, Inc. | FTax withholding Common Stock | -2,693 | $4.38 | $12k | 1,074,990 | 5 d ago |
| Feb 13, 2024 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 317,802 | Nov 25, 2025 |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 442,802 | Nov 25, 2025 |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 742,802 | Nov 25, 2025 |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 1,578,182 | Nov 25, 2025 |
| Jul 7, 2025 | ABSI Absci Corp | AGrant or award Stock Option (right to buy)derivative | +178,400 | $0.00 | $0 | 178,400 | Jul 9, 2025 |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +28,500 | $0.00 | $0 | 28,500 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.